International Congress on Access to Medicines and Human Rights' Full Schedule
Keep reading
COVID19- South America: Gilead block access to coronavirus treatment for 440 million people
Buenos Aires, May 12th 2020. Yesterday the american company Gilead Sciences signed non exclusive voluntary licenses with five generic manufacturers from…
RedLAM in Geneva: A week of actions against the Corporate Power and to reclaim Peoples Sovereignty
Between October 12th and 19th, RedLAM is in Geneva participating of the “Week of Peoples”, a wake up call to social movements worldwide to contribute to the…
Fundación GEP filed patent opposition on Hepatitis C treatment
Fundación GEP filed an opposition to the patent application claimed by Gilead over the combination Sofosbuvir + Velpatasvir. This is the third opposition…